Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Anthony Quinn > Profile

Anthony Quinn

Affiliations

  • at Generation Bio Co. (GBIO), 2025-01-14
  • President & Ceo at Aeglea Biotherapeutics Inc. (AGLE), 2022-03-18
  • Director at Kaleido Biosciences Inc. (KLDO), 2020-07-01
  • Evp, Cmo, & Head Of R&D at Synageva Biopharma Corp (GEVA), 2015-06-23
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Generation Bio Co.
 GBIO $0.97 85,000 299,286 2025-01-13 Filing
Generation Bio Co.
 GBIO $0.96 125,791 214,286 2025-01-10 Filing
Generation Bio Co.
 GBIO $1.41 88,495 88,495 2023-12-01 Filing
Aeglea Biotherapeutics Inc.
 AGLE $2.34 80,079 Officer, Director 550,540 2022-03-16 Filing
Aeglea Biotherapeutics Inc.
 AGLE $1.86 42,417 Officer, Director 473,461 2022-03-15 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Synageva Biopharma Corp
 GEVA $110.00 10,000 5,637 2015-04-27 Filing
Synageva Biopharma Corp
 GEVA $108.00 10,000 5,637 2015-04-21 Filing
Synageva Biopharma Corp
 GEVA $105.00 10,000 15,637 2015-04-15 Filing
Synageva Biopharma Corp
 GEVA $93.76 29,503 15,637 2015-04-06 Filing
Synageva Biopharma Corp
 GEVA $72.88 300 25,595 2014-09-02 Filing